Viewing Study NCT04689659


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2025-12-26 @ 1:05 AM
Study NCT ID: NCT04689659
Status: COMPLETED
Last Update Posted: 2025-05-18
First Post: 2020-12-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma
Sponsor: Beijing Boren Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module